Post-pyloric Feeding and Feeding Intolerance in ARDS Patients Receiving Prone Position Ventilation

March 24, 2026 updated by: Ling Liu, Southeast University, China

Post-pyloric Feeding and Feeding Intolerance in ARDS Patients Undergoing Prone Position Ventilation: a Single-center, Retrospective Study

Evidence remains limited regarding the optimal enteral nutrition (EN) route for acute respiratory distress syndrome (ARDS) patients undergoing prone positioning. This study aimed to explore the association of post-pyloric feeding with feeding intolerance (FI), specifically in that population.

Study Overview

Status

Completed

Conditions

Detailed Description

This single-center retrospective study included adult patients with ARDS who received prone position ventilation at Zhongda Hospital, Southeast University, between July 30, 2016, and April 30, 2024. The primary outcome was the incidence of FI, defined as the failure to achieve an enteral energy intake of 17.5 kcal/kg/day within 72 hours of initiating EN. The statistical approaches utilized included multivariate regression, inverse probability weighting model, and marginal structural cox model to ensure the robustness of our findings. Subgroup analyses were also performed.

Study Type

Observational

Enrollment (Actual)

319

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

intensive care unit

Description

Inclusion Criteria:

  1. age ≥ 18 years old
  2. ARDS, defined by the Berlin standard
  3. patients receiving prone position ventilation treatment

Exclusion Criteria:

  1. No enteral nutrition within 4 days after initiation of invasive mechanical ventilation
  2. Duration of invasive mechanical ventilation <72 hours after initiation of enteral nutrition
  3. Prone positioning initiated >3 days after EN
  4. Duration of each prone session <12 hours
  5. Severe acute pancreatitis
  6. Contraindications to early enteral nutrition

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
gastric feeding
Patients receiving gastric feeding
post-pyloric feeding
Patients receiving post-pyloric feeding

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of FI
Time Frame: at day 3
Incidence of feeding intolerance during enteral nutrition within 72 hours of initiating EN
at day 3

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
28-day mortality
Time Frame: at day 28
mortality in Day 28
at day 28
Incidence of enteral nutrition-related complications
Time Frame: up to 3 days
Incidence of feeding-related complications during enteral nutrition
up to 3 days
ICU mortality
Time Frame: up to 24 months
the survival rate(survival/total) during ICU stay
up to 24 months
VFDs at day 28
Time Frame: 28 days
defined as the number of days between successful weaning from MV and day 28 after study enrollment
28 days
Length of ICU stay
Time Frame: up to 24 months
the number of days from ICU admission to ICU discharge or death
up to 24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: ling liu, phD, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 30, 2016

Primary Completion (Actual)

April 30, 2024

Study Completion (Actual)

December 30, 2024

Study Registration Dates

First Submitted

February 12, 2026

First Submitted That Met QC Criteria

February 12, 2026

First Posted (Actual)

February 19, 2026

Study Record Updates

Last Update Posted (Actual)

March 30, 2026

Last Update Submitted That Met QC Criteria

March 24, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • prone nutrition

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Clinical Outcomes

Subscribe